Skip to main content
. 2016 Apr 22;7(24):37297–37304. doi: 10.18632/oncotarget.8934

Table 3. Best response to mTPF and type of treatment after induction.

Best response to TPF N %
Overall response rate 40 83
Complete response 9 19
Partial response 31 65
Stable disease 5 10
Progressive disease 1 2
Not evaluable 2 4
Surgery of the tumor 8 17
Mutilating 4 8
Non-mutilating 4 8
Node dissection (of whom 14 had only node dissection) 20 42
Radiotherapy 39 81
Exclusive 22 46
Potentiated 17 35
Weekly cisplatin 8 17
Weekly cetuximab 6 12
Unknown 3 6